. Overall, the H-O scales, RC scales, and Specific Problem scales display meaningful relationships to Axis I and Axis II disorders conceptualized by the DSM-IV. In addition, the RC scales demonstrate a moderate improvement in validity over the standard Clinical scales. Theoretical and clinical implications are considered.
Within the field of clinical psychology, the Minnesota Multiphasic Personality Inventory-2 (MMPI-2; Butcher et al., 2001 ) is worldwide the most widely used and researched self-report measure of psychopathology and personality characteristics (Camara, Nathan, & Puente, 2000) . The most recent update in the long history of the MMPI-2 is the development of the MMPI-2 Restructured Form (MMPI-2-RF; . The MMPI-2-RF, with its RC scales and three H-O scales based on the RC scales as its core components, is shorter than the MMPI-2 (i.e., 338 items versus 567 items) and contains one new and seven revised Validity scales, 23 Specific Problem Scales, two Interest Scales, and five revised PSY-5 scales. The current investigation presents a predictive validity study of the H-O scales, RC scales, and Specific Problem scales with respect to the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV, 4th ed.; American Psychiatric Association, 1994) Axis I and Axis II disorders by First, Spitzer, Gibbon, and Williams (1995) and First, Spitzer, Gibbon, Williams, and Benjamin (1997; e.g., SCID-I and SCID-II, respectively) .
The RC scales were developed by Tellegen et al., (2003) to solve some major interpretive difficulties of the MMPI Clinical scales. Among these difficulties are the high intercorrelations due to item overlap and common variance related to psychopathology or emotional distress in general (but not to specific diagnoses) (Helmes & Reddon, 1993) . Also, the Clinical scale item pool contains a vast amount of information regarding a broad range of psychopathology. In developing the RC scales, Tellegen et al. (2003) wanted to preserve this valuable information of the Clinical scales and simultaneously improve their uniqueness and discriminant validity.
Construction of the RC scales was performed in four steps. First, the conceptualization and labeling of the common distress factor in the Clinical scales was guided by the two-factor model of mood and affect (Tellegen, Watson, & Clark, 1999) . This distress factor was labeled Demoralization and was constructed through factor analysis of items of Scale 2 (Depression) and Scale 7 (Psychasthenia), seeing that these scales have the most demoralization-related items. Then, these demoralization items were added to each Clinical scale, and a combined item factor analysis was performed, which for each Clinical scale yielded a demoralization factor and a distinctive factor representing the core element of that particular Clinical scale. Items that defined these core elements of each Clinical scale were then correlated to the entire MMPI-2 item pool. Items from the MMPI-2 item pool with unique and strong correlations were added to these core elements to enhance internal consistency and content representativeness of the RC scales. Finally, the scales were further improved by correlating them with relevant extra test criteria and by removing items that displayed poor validity. No item overlap between any RC scales was allowed. Nine RC scales were developed in this manner; no RC scales were developed for Clinical scale 5 and 0 as they are not measures of psychopathology. The restructuring of RC3 (Cynicism) was a bit different: A separate factor marked as naïveté was identified as the distinctive core component of Scale 3 (Hysteria) because items reflecting somatic complaints were already assigned to RC1 (Somatic Complaints). Items reflecting naïveté were then scored inversely, and the final scale RC3 was named Cynicism, which also contains items of the original Scale 6 (Paranoia).
Specific Problem scales were developed to measure distinctive components from the Clinical scales that were not captured by the RC scales, in addition to some facets of the RC scales that require separate assessment -for example, substance abuse, which is part of RC4 (Antisocial Behavior; .
Factor analysis of the RC scales revealed three underlying dimensions representing internalizing problems, externalizing problems, and thought disorders. These three dimensions were the primary markers of three Higher Order (H-O) scales Emotional/Internalizing Dysfunction (EID) [based mainly on the items from Demoralization (RCd), Low Positive Emotions (RC2) and Dysfunctional Negative Emotions (RC7)], Behavioral/Externalizing Dysfunction (BXD) [based on items from Antisocial Behavior (RC4) and Hypomanic Activation (RC9)] and Thought Dysfunction (THD) [consisting of items from the Ideas of Persecution (RC6) and Aberrant Experiences (RC8) scales]. These dimensions parallel the classical MMPI code types 2/7, 4/9, and 6/8 and are fairly consistent with the higher-order factors found among common mental disorders (Markon, 2010) . Simms, Casillas, Clark, Watson, and Doebbeling (2005) compared the RC scales with the Clinical scales with respect to the Schedule for Nonadaptive and Adaptive Personality (SNAP; Clark, 1993) and the SCID in a sample of psychology clinic clients (N = 285) and a sample of military veterans (N = 567). They found that RCd, RC1, RC2, and RC7 were related to current and lifetime diagnosis of depression from the SCID, with a medium effect size (i.e., .30 ≤ r < .50; Cohen, 1992) . However, depressive disorders were better predicted by Scale 2 than by RC2. Ratings of anxiety disorders were correlated most strongly with the restructured and "traditional" versions of Scales 1, 2, 7, and 8 as well as with RCd. Anxiety disorders were better predicted by Scale 7 than by RC7. RC1 and Scale 1 displayed equal relations to ratings of somatoform disorders, whereas substance abuse disorders were better predicted by RC4 than by Scale 4. Simms and colleagues did not consider the MMPI-2-RF H-O scales, nor did they consider SCID-II classifications for personality disorders (PDs).
The study by Simms and colleagues (2005) is the only one so far to relate the RC scales to the SCID-I. To our knowledge, no study has investigated the relationship between the RC scales and the SCID-II. This is remarkable because the SCID-I is commonly seen as the "golden standard" in the assessment of clinical diagnoses (Shear et al., 2000) . The SCID-I is therefore a valuable instrument for exploring correlates of the RC scales, although the RC scales were not explicitly designed to predict clinical diagnoses (as the Clinical scales were). Arbisi, Sellbom, and Ben-Porath (2008) suggest the use of structured diagnostic interviews in validation studies to allow for an investigation of the diagnostic implications of elevated scores on the RC scales. In addition, the SCID-II could be considered an appropriate measure for the evaluation of PDs because personality-disordered patients often lack self-insight (Westen, 1997) , and a diagnostic interview provides the possibility to ask for elaborations or concrete examples for clarification.
Presently, there is paucity in research on the RC scales outside the United States, while crosscultural comparisons are needed to investigate whether U. S. validation studies on the RC scales may be generalized to other (Western) countries. For all of these reasons, we decided to investigate the relationships of the H-O scales, RC scales, Specific Problem scales, and standard Clinical scales with the SCID-I and SCID-II. Based on prior research (e.g., Simms et al., 2005) , we hypothesized that overall the RC scales and Clinical scales would demonstrate comparable convergent and divergent validity with respect to the SCID-I. Based on research with the SNAP (Simms et al., 2005) , we hypothesized that the RC scales would demonstrate better validity with respect to the SCID-II than their Clinical scale counterparts. In addition, we hypothesized that, for several diagnostic criteria, the Specific Problem scales would demonstrate strong correlation [e.g., Stress/Worry (STW) and Anxiety (AXY) for the anxiety-related disorders, Substance Abuse (SUB) for substance use disorders and the Interpersonal Scales for the schizoid, histrionic, narcissistic, avoidant, and dependent PDs; .
Method Participants
All participants (N = 101) were recruited in an outpatient mental health institute in The Netherlands. Data were collected as part of the clinical routine, and the confidentiality of participants' identities was maintained throughout the study process. Participants were excluded from the study who had MMPI-2 profiles that met the following criteria: Cannot Say raw scores ≥ 30, VRIN and TRIN T score ≥ 80 and L > 80 (Butcher et al., 2001 ); or MMPI-2-RF profiles that met the following criteria: Cannot Say raw scores ≥ 15, VRIN-r and TRIN-r T score ≥ 80, Fp-r ≥ 100 and L-r ≥ 80 . Seven participants were excluded based on these criteria, one of whom demonstrated VRIN = 80 but no significant elevations on the F scale or Clinical scales. The other six excluded participants displayed high F scores (103 ≤ F T score ≤ 120) and Fp scores (102 ≤ Fp T score ≤ 117) and met criteria for several PDs (M = 3, range 2-8) including borderline PD. The final sample consisted of 94 participants (46 men and 48 women) with a mean age of 36.6 years at day of testing (SD = 8.99; range 21-57 years).
Measurements
The Dutch language version of the MMPI-2 was translated and standardized for Belgium and the Netherlands by Derksen, De Mey, Sloore, and Hellenbosch (1993) . Detailed information about the translation process and the psychometric properties of the MMPI-2 and MMPI-2-RF scales in the Dutch normative sample is provided by Derksen et al. (1993) and Derksen (2008, 2010) . No commercial version of the Dutch MMPI-2-RF is available yet, and the Dutch language version of the MMPI-2-RF is available only for scientific research and validation studies. We used uncorrected raw scores in the analyses.
The SCID-I (First, Spitzer, Gibbon, & Williams, 1995; Groenestijn, Akkerhuis, Kupka, Schneider, & Nolen, 1998) and SCID-II (First, Spitzer, Gibbon, Williams, & Benjamin, 1997; Weertman, Arntz, & Kerkhofs, 2000) are widely used structured clinical interviews to measure clinical syndromes (CSs) and PDs based on criteria from the DSM-IV. Three interviewers accounted for all the interviews in the current research. These interviewers were adequately trained and experienced in administering the interview to guarantee good interrater reliability. When interviewers are sufficiently trained, the SCID-I and SCID-II showed excellent interrater reliability and test-retest reliabilities in diverse studies (Weertman, Arntz, Dreessen, Van Velzen, & Vertommen, 2003; Zanarini et al., 2000) .
In the analyses, we reduced all SCID-I classifications to four broad disorders in line with Simms and colleagues (2005) . Participants were classified with a depressive disorder if they met criteria for one or more depression-related disorders (except bipolar disorders), an anxiety disorder if they met criteria for any of the anxiety disorders, and with a somatoform disorder if they met criteria for any of the somatoform disorders or for fibromyalgia, irritable bowel syndrome or chronic fatigue syndrome (Wesley & White, 2004) . A category substance use disorder (SUD) was made for people with alcohol or drug abuse and/or dependency. We did not create a category for psychotic disorders as the frequency of this type of disorders was too small in our outpatient sample. Only current diagnoses were used in the analyses. For the PDs we calculated number of criteria met, instead of diagnoses.
Statistical Analyses
First, we calculated that a minimum of 85 participants was needed to realize a power of .80, based on α = .05 and given an expected medium effect size (Cohen, 1992; Simms et al., 2005) . Reliability coefficients and intercorrelations were calculated for the MMPI-2 and MMPI-2-RF scales. In addition, we investigated the diagnostic overlap in the current sample. Then, zero order correlations were calculated for the H-O scales, RC scales, Specific Problem scales, and standard Clinical scales with the SCID-I and II classifications. We calculated Fisher's Z to test the differences in correlations between the Clinical scales and the RC scales with the SCID-I and II; Cohen's q was calculated as effect size for these comparisons. Because of the large number of comparisons and Z-tests, we set the p-value for significance conservatively to .01 for all the analyses.
Results
Detailed information about reliability statistics of the H-O scales, RC scales, Specific Problem scales and Clinical scales, intercorrelations among RC scales and Clinical scales, and differences in average T-scores for RC scales and corresponding Clinical scales are available on request from the first author. In terms of DSM-IV, there was considerable diagnostic overlap in the current sample. For example, the mean number of current Axis I disorders was 2.88 (SD = 2.45). Of the 50 participants with depressionrelated disorders, 35 (70%) also met criteria for at least one of the anxiety disorders. On the other hand, of the 54 patients with anxiety-related disorders, 35 (65%) patients also met criteria for one of the depression-related disorders. The mean number of PDs in the current sample was 1.54 (SD = 1.68; range 0-7). The mean number of PDs for participants who met criteria of at least one PD (N = 58) was 2.5 (range 1-7). The avoidant and borderline PD had the highest frequencies in the sample (i.e., 26 and 23, respectively). Table 2 provides correlations for the Specific Problem scales with the same criteria. As Table 1 indicates, the RC scales demonstrate convergent and discriminant validity in relation to the SCID-I and II classifications: RCd (Demoralization) has a strong correlation with depressive disorders and a medium correlation with anxiety-related disorders. RC2 (Low Positive Emotions) demonstrates the strongest relationship with depressive disorders, whereas RC7 (Dysfunctional Negative Emotions) demonstrates its strongest relationship with anxiety-related disorders. RC1 (Somatic Complaints) displays a medium relationship with somatoform disorder (r = .33), and RC4 (Antisocial Behavior) is clearly related to SUD (i.e., medium effect, r = .30). The RC scales also exemplify meaningful relationships with the PDs. For example, RC6 (Ideas of Persecution) shows a unique and medium correlation with the paranoid PD, and RC4 (Antisocial Behavior) demonstrates a strong correlation with the antisocial PD. Concerning the Specific Problem scales, Anxiety (AXY) demonstrated a small correlation (r = .24) with the anxiety-related disorders, whereas Stress/Worry (STW) displayed a medium correlation (r = .43) with these disorders. As hypothesized, Substance Abuse (SUB) showed a medium correlation with SUD. Juvenile Conduct Problems (JCP) demonstrated a strong relationship with antisocial PD and Suicidal/Death ideation with borderline PD. Shyness (SHY) was strongly correlated with the avoidant PD and Activation (ACT; heightened excitation and energy level) with borderline PD. Disaffiliativeness (DSF; disliking people and being around them) showed medium correlations with depressive, schizoid and avoidant PD. The Interpersonal Scales were not related to the histrionic and narcissistic PDs.
We did compare correlations for RC scales and Clinical scales with DSM-IV Axis I and Axis II disorders. Here, we found some significant differences in correlations, but none of these differences reached a large effect size (i.e., Cohen's q = .50). For example, RC4 (Antisocial Behavior) displayed a stronger correlation with antisocial PD than Scale 4 did (i.e., Z = 3.10; p < .01; Cohen's q = .46). Similarly, RC3 (Cynicism) demonstrates stronger relationships with schizoid PD than Scale 3 (Z = 2.67; p < .01; Cohen's q = .40). We also compared our correlation table (RC scales with Axis I classifications) with correlations found by Simms and colleagues (2005) in a sample with 564 military veterans (88% male). None of 36 comparisons demonstrated a significant difference (p < .01).
Discussion
As hypothesized, the RC scales demonstrate convergent and discriminant validity with respect to the SCID-I and II. For example, our findings concerning the relationships between RC2 and RC7 and the DSM-IV measures for anxiety and depression were in line with Tellegen's model (1985) . According to this model, low positive emotions (reflected by RC2) are distinctive for depressive disorders, whereas high negative affectivity (i.e., RC7) is related to anxiety. The common variance that is often seen in depression, and anxiety can be considered as a higher order factor conceptualized as demoralization (Tellegen et al., 2003) . In our sample, RC2 (Low Positive Emotions) had a stronger relationship with depression than RC7 (Dysfunctional Negative Emotions), whereas for anxiety the opposite was true. RCd (Demoralization) has equal correlations with both anxiety and depression. RC3 (Cynicism) displayed medium correlations with the paranoid and passive-aggressive PDs. High scores on RC3 reflect cynical beliefs about others, believing others look out only for their own interests, and being distrustful of others, which are indeed core beliefs of the paranoid and passive aggressive PDs (Millon & Davis, 1996) . RC9 (Hypomanic Activation) exemplifies medium-size correlations with the paranoid, borderline, antisocial, and passive aggressive PDs. Elevated scores on RC9 reflect aggression, poor impulse control, mood instability, sensation seeking, and other forms of undercontrolled behavior . However, high scores on RC9 are also associated with narcissistic personality features, although the correlation of RC9 with the narcissistic PD is small in the current sample. This may be due to the fact that the criteria for the narcissistic PD from the SCID-II are very obvious and transparent and therefore not easy to admit in an interview. In our sample only 4 persons met the criteria for a narcissistic PD. Simms et al. (2005) found a strong correlation for RC9 with the narcissistic PD in the SNAP.
The Specific Problem scales showed meaningful relationships with the DSM-IV classifications. The internalizing scales were related primarily to the internalizing disorders, whereas the externalizing scales were related primarily to SUD and antisocial PD. Contrary to our hypotheses, we didn't find significant correlations for the Interpersonal scales and the narcissistic and histrionic PDs, probably because of low frequencies of these disorders in the current sample. Anxiety (AXY; pervasive anxiety, frights, frequent nightmares) showed only a small correlation with anxietyrelated disorders, whereas it showed medium correlations with depressive, borderline, and paranoid PD. A possible explanation might be that the anxiety-related disorders in the current sample is a broad dimension, whereas the AXY scale is a narrow defined construct.
Our hypotheses for comparisons of both sets of scales with the DSM-IV disorders were only partially confirmed. RC scales measuring externalizing behaviors and psychotic symptoms demonstrate some improvement in convergent and discriminant validity over their Clinical scale counterparts. For example, RC4, RC6, and RC8 are less saturated with depression-related variance and therefore display better divergent validity with respect to depression-related disorders. However, for RC scales measuring internalizing pathology this is not the case; these RC scales display no improvement compared to the Clinical scales with respect to internalizing disorders. That being said, the RC scales definitely do not perform worse than their Clinical scale counterparts with respect to the SCID, although these scales were not designed to predict these diagnoses. Moreover, the RC scales have fewer items and thus could be seen as more efficient. Overall, we agree with Simms and colleagues (2005) , who stated that the RC scales "appear to represent a modest psychometric improvement over the standard clinical scales" (p. 357). Interestingly, our findings were very much in correspondence with findings by Simms and colleagues, offering a first indication for the generalizability of U.S. validation studies to the Dutch language version of the MMPI-2.
Potential limitations of the current study must also be considered. First of all, we had to reduce the DSM-IV Axis I disorder to four broad categories (without a category with psychotic disorders) because of the relative small sample and the low frequency of some severe psychiatric disorders. In addition, the SCID classifications were not mutually exclusive; there is considerable diagnostic overlap in the current sample. This limits our ability to draw inferences about discriminant validity. On the other hand, one should have access to an overwhelming big sample with an extensive variety of problems and disorders to capture all 374 classifications in DSM-IV (APA, 1994) . Also, comorbidity is widespread among common mental disorders (Krueger, 1999) . Moreover, the categories we made are the most common ones in mental health practice, and we calculated that our sample should be big enough to reach a power of .80. Furthermore, we included patients with a variety of Axis I and Axis II disorders, which reduces the possibility to restrict range effects. Another limitation might be that we did not consider some of the MMPI-2 content and PSY-5 scales that show considerable conceptual overlap with the RC scales (Nichols, 2006; Van der Heijden et al., 2008) . That would make a fairer comparison if one wants to evaluate possible redundancy of the RC scales (Nichols, 2006 ). Yet, these particular scales do not appear in the MMPI-2-RF so the possible redundancy is not an issue for clinicians who solely use the new MMPI-2-RF scales.
An interesting direction for future research could be the connections of the MMPI-2-RF conceptualizations with current proposals for the DSM-5 (personality) disorders. Furthermore, the treatment utility (Nelson-Gray, 2003) of the MMPI-2-RF scales should be considered in future research. Ultimately, clinicians are most interested in the way these scales can add in the prediction of relevant issues such as treatment response and treatment outcome.
As mentioned above, there is no commercial version of the MMPI-2-RF available yet in the Netherlands, but publication is planned. In the United States, both MMPI-2 versions are available at the same time. So which one to chose? As far as the current research is concerned, the H-O scales, RC scales, and Specific Problem scales show meaningful correlations with the SCID-I and II classifications, although they were not explicitly designed to predict these diagnoses. Moreover, the RC scales show a moderate improvement compared to the more comprehensive Clinical scales. The RC scales show the same reliability statistics, less intercorrelations (Tellegen et al., 2003; Van der Heijden et al., 2008) , and slightly better discriminant validity than the Clinical scales. In addition, the MMPI-2-RF has 40% less items. The RC scales provide an efficient and homogeneous measure, whereas the Clinical scales may show more syndrome fidelity and can rest on an enormous empirical tradition. However, new research on the MMPI-2 is becoming more and more related to the RC scales and H-O scales instead of the Clinical scales. So the development of an equally impressive and extensive research base for the MMPI-2-RF scales to draw upon during test interpretation seems just a matter of time. That makes the MMPI-2-RF more promising for the future.
